Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 6 of 6 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 10/30/19
End: 05/24/22
Due: 05/24/23
Phase: N/A
Priority: Normal
Start: 08/09/21
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 08/02/25
End: 01/02/28
Due: 01/02/29
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The KHENERGYC Study | NCT04846036 | Khondrion BV | user2@example.com | None | 2021-02-01 | 2025-12-01 | 2026-12-01 | - | - | 2025-07-14 |
| The KHENERGY Study | NCT02909400 | Khondrion BV | user2@example.com | None | 2016-09-30 | 2017-07-31 | 2018-07-31 | - | - | 2025-07-14 |
| The KHENERGYZE Study | NCT04165239 | Khondrion BV | user2@example.com | None | 2019-10-30 | 2022-05-24 | 2023-05-24 | - | - | 2025-07-14 |
| The KHENEREXT Study | NCT04604548 | Khondrion BV | user2@example.com | None | 2021-08-09 | 2023-06-01 | 2024-06-01 | - | - | 2025-07-14 |
| A Dose-escalating Clinical Trial With KH176 | NCT02544217 | Khondrion BV | user2@example.com | None | 2015-05-31 | 2015-10-31 | 2016-10-31 | - | - | 2025-07-14 |
| KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases | NCT06451757 | Khondrion BV | user2@example.com | None | 2025-08-02 | 2028-01-02 | 2029-01-02 | - | - | 2025-07-14 |